Cerecor Inc.
NUCLEOTIDE PRODRUGS
Last updated:
Abstract:
The invention relates to nucleotide prodrugs and pharmaceutical preparations thereof. The invention further relates using the prodrugs of the invention in the treatment of mitochondrial DNA (mtDNA) depletion syndrome (MDS).
Status:
Application
Type:
Utility
Filling date:
7 Jan 2019
Issue date:
13 May 2021